Elutia (ELUT) Free Cash Flow (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.81% |
| Dec 31, 2025 | -628.60% |
| Sep 30, 2025 | 57.79% |
| Jun 30, 2025 | 8.92% |
| Mar 31, 2025 | 25.84% |
| Dec 31, 2024 | -210.80% |
| Sep 30, 2024 | 8.22% |
| Jun 30, 2024 | -63.03% |
| Mar 31, 2024 | 70.81% |
| Dec 31, 2023 | -75.51% |
| Sep 30, 2023 | -109.58% |
| Jun 30, 2023 | 53.74% |
| Mar 31, 2023 | 0.58% |
| Dec 31, 2022 | 4.49% |
| Sep 30, 2022 | 48.59% |
| Jun 30, 2022 | -48.36% |
| Mar 31, 2022 | -15.16% |
| Dec 31, 2021 | -100.69% |
| Sep 30, 2021 | -253.82% |
| Jun 30, 2021 | 82.98% |
| Mar 31, 2021 | 3.25% |
| Dec 31, 2020 | -229.31% |
| Sep 30, 2020 | 58.56% |
| Jun 30, 2020 | -29.61% |
| Mar 31, 2020 | -13.64% |